Evidence map›Paper›PMID 25873012›Full record

ArticleEuropean journal of human genetics : EJHG2015

Pathogenic mitochondrial mt-tRNA(Ala) variants are uniquely associated with isolated myopathy.

Diana Lehmann, Kathrin Schubert, Pushpa R Joshi, Steven A Hardy, Helen A L Tuppen, Karen Baty, Emma L Blakely, Christian Bamberg, Stephan Zierz, Marcus Deschauer and 1 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Intimate Relations-Mitochondria and Ageing.International journal of molecular sciences · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Diana LehmannDepartment of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
Kathrin SchubertDepartment of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
Pushpa R JoshiDepartment of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
Steven A HardyWellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
Helen A L TuppenWellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
Karen BatyWellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
Emma L BlakelyWellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
Christian BambergDepartment of Neurology, Rhein-Mosel-Fachklinik, Andernach, Germany.
Stephan ZierzDepartment of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
Marcus DeschauerDepartment of Neurology, University of Halle-Wittenberg, Halle (Saale), Germany.
Robert W TaylorWellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
Martin Luther University Halle-Wittenberg · DENewcastle University · GBWellcome Centre for Mitochondrial Research · GB

Funding

Medical Research Council G0601943Medical Research Council MR/K000608/1Wellcome Trust 096919Wellcome Trust 096919Z/11/Z
6 · The paper itself

Abstract

Pathogenic mitochondrial DNA (mtDNA) point mutations are associated with a wide range of clinical phenotypes, often involving multiple organ systems. We report two patients with isolated myopathy owing to novel mt-tRNA(Ala) variants. Muscle biopsy revealed extensive histopathological findings including cytochrome c oxidase (COX)-deficient fibres. Pyrosequencing confirmed mtDNA heteroplasmy for both mutations (m.5631G>A and m.5610G>A) whilst single-muscle fibre segregation studies (revealing statistically significant higher mutation loads in COX-deficient fibres than in COX-positive fibres), hierarchical mutation segregation within patient tissues and decreased steady-state mt-tRNA(Ala) levels all provide compelling evidence of pathogenicity. Interestingly, both patients showed very high-mutation levels in all tissues, inferring that the threshold for impairment of oxidative phosphorylation, as evidenced by COX deficiency, appears to be extremely high for these mt-tRNA(Ala) variants. Previously described mt-tRNA(Ala) mutations are also associated with a pure myopathic phenotype and demonstrate very high mtDNA heteroplasmy thresholds, inferring at least some genotype:phenotype correlation for mutations within this particular mt-tRNA gene.

Indexed as

MutationAdultAgedBase SequenceDNA, MitochondrialElectron Transport Complex IVFemaleHumansMolecular Sequence DataMuscular DiseasesRNA, Transfer, AlaDNA, MitochondrialElectron Transport Complex IVRNA, Transfer, Ala

Identifiers

PMID25873012
PMCPMC4519577
OpenAlexW2018764786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.